ECMC-UK
@ecmc-uk.bsky.social
A network like no other. Accelerating early phase cancer research through collaboration to deliver meaningful outcomes for patients
Professor Karen Brown (Leicester ECMC) is discussing her prevention trial COLO-PREVENT at #PrevConf25. Prof Brown is also the co-chair of the ECMC supported UK Therapeutic Cancer Prevention Network 👉https://www.ecmcnetwork.org.uk/groups/uk-therapeutic-cancer-prevention-network-group-uktcpn
June 27, 2025 at 10:16 AM
Professor Karen Brown (Leicester ECMC) is discussing her prevention trial COLO-PREVENT at #PrevConf25. Prof Brown is also the co-chair of the ECMC supported UK Therapeutic Cancer Prevention Network 👉https://www.ecmcnetwork.org.uk/groups/uk-therapeutic-cancer-prevention-network-group-uktcpn
Check out the work of the UK Therapeutic Cancer Prevention Network at #PrevConf25 (poster 99). The group champions prevention research and encourages collaboration & knowledge exchange. Find out more: www.ecmcnetwork.org.uk/groups/uk-th...
June 25, 2025 at 2:17 PM
Check out the work of the UK Therapeutic Cancer Prevention Network at #PrevConf25 (poster 99). The group champions prevention research and encourages collaboration & knowledge exchange. Find out more: www.ecmcnetwork.org.uk/groups/uk-th...
Today Karolin Kroese, Programme Lead in the #ECMC Programme Office is taking part in a panel discussion on clinical trials in oncology at the Outsourcing in Clinical Trials UK & Ireland 2025 conference #clinicaltrials
June 10, 2025 at 9:31 AM
Today Karolin Kroese, Programme Lead in the #ECMC Programme Office is taking part in a panel discussion on clinical trials in oncology at the Outsourcing in Clinical Trials UK & Ireland 2025 conference #clinicaltrials
The ECMC Programme Office is on the ground at #ASCO25! We're in Chicago connecting with global partners, championing the UK’s leadership in experimental cancer medicine, and supporting our network’s investigators across the event! #ECMC #CancerResearch #ClinicalTrials
@ascocancer.bsky.social
@ascocancer.bsky.social
May 30, 2025 at 8:28 PM
The ECMC Programme Office is on the ground at #ASCO25! We're in Chicago connecting with global partners, championing the UK’s leadership in experimental cancer medicine, and supporting our network’s investigators across the event! #ECMC #CancerResearch #ClinicalTrials
@ascocancer.bsky.social
@ascocancer.bsky.social
It's International Clinical Trials Day and the team is at the #RDF25 presenting on how the ECMC has contributed to the implementation of NCVR for complex early phase and advanced therapy oncology trials #clinicaltrials
May 20, 2025 at 10:48 AM
It's International Clinical Trials Day and the team is at the #RDF25 presenting on how the ECMC has contributed to the implementation of NCVR for complex early phase and advanced therapy oncology trials #clinicaltrials
The ECMC team are up in Manchester for a few days at the RDF Conference and tomorrow we will be presenting on all the work we've been doing around study set-up #RDF25
May 19, 2025 at 8:07 AM
The ECMC team are up in Manchester for a few days at the RDF Conference and tomorrow we will be presenting on all the work we've been doing around study set-up #RDF25
That’s a wrap on an insightful, energising day at the #ECMC2025 Network Meeting! Huge thanks to all speakers, panellists & attendees. Let’s keep the momentum going! 💪
May 7, 2025 at 4:06 PM
That’s a wrap on an insightful, energising day at the #ECMC2025 Network Meeting! Huge thanks to all speakers, panellists & attendees. Let’s keep the momentum going! 💪
Now Yemi Akala (Leicester ECMC) takes us through the opportunities and pitfalls of decentralised trial models. What’s the future of remote oncology research? #ECMC2025 #DecentralisedTrials
May 7, 2025 at 3:30 PM
Now Yemi Akala (Leicester ECMC) takes us through the opportunities and pitfalls of decentralised trial models. What’s the future of remote oncology research? #ECMC2025 #DecentralisedTrials
Next up... Prof. Matthew Sydes (@england.nhs.uk) on unlocking the full potential of healthcare systems data to accelerate early phase trial delivery. #ECMC2025 #DataDrivenResearch
May 7, 2025 at 3:07 PM
Next up... Prof. Matthew Sydes (@england.nhs.uk) on unlocking the full potential of healthcare systems data to accelerate early phase trial delivery. #ECMC2025 #DataDrivenResearch
Our first session explores Patient Centric Tech! How can innovation break down barriers to trial access? Steve Nabarro & Ben Hood explore tech that’s designed with patients at its heart. #ECMC2025 #PatientCentric
May 7, 2025 at 2:51 PM
Our first session explores Patient Centric Tech! How can innovation break down barriers to trial access? Steve Nabarro & Ben Hood explore tech that’s designed with patients at its heart. #ECMC2025 #PatientCentric
Session C: Equity of Access 🌍
Representation matters. This session looks at how ECMC can improve equity in trial access—through design, engagement, and tackling health inequality. #ECMC2025 #InclusiveResearch
Representation matters. This session looks at how ECMC can improve equity in trial access—through design, engagement, and tackling health inequality. #ECMC2025 #InclusiveResearch
May 7, 2025 at 1:39 PM
Session C: Equity of Access 🌍
Representation matters. This session looks at how ECMC can improve equity in trial access—through design, engagement, and tackling health inequality. #ECMC2025 #InclusiveResearch
Representation matters. This session looks at how ECMC can improve equity in trial access—through design, engagement, and tackling health inequality. #ECMC2025 #InclusiveResearch
Session B: Translating Policy to Practice 🏛️➡️🧪
Turning national strategy into local success. This breakout dives into real-world approaches to improving trial setup and delivery. #ECMC2025 #ResearchPolicy
Turning national strategy into local success. This breakout dives into real-world approaches to improving trial setup and delivery. #ECMC2025 #ResearchPolicy
May 7, 2025 at 1:38 PM
Session B: Translating Policy to Practice 🏛️➡️🧪
Turning national strategy into local success. This breakout dives into real-world approaches to improving trial setup and delivery. #ECMC2025 #ResearchPolicy
Turning national strategy into local success. This breakout dives into real-world approaches to improving trial setup and delivery. #ECMC2025 #ResearchPolicy
Session A: Quantum Leap in Oncology Research 🚀
What breakthroughs will redefine cancer care? Experts explore paradigm-shifting innovations—from T-cells to ADCs to cancer vaccines. #ECMC2025
What breakthroughs will redefine cancer care? Experts explore paradigm-shifting innovations—from T-cells to ADCs to cancer vaccines. #ECMC2025
May 7, 2025 at 1:28 PM
Session A: Quantum Leap in Oncology Research 🚀
What breakthroughs will redefine cancer care? Experts explore paradigm-shifting innovations—from T-cells to ADCs to cancer vaccines. #ECMC2025
What breakthroughs will redefine cancer care? Experts explore paradigm-shifting innovations—from T-cells to ADCs to cancer vaccines. #ECMC2025
How can ECMC build international partnerships? Dr Natalie Cook (@oncocook) & Emma Kinloch (@London_Em1) join the international Consortia conversation on learning globally, acting locally. #ECMC2025 #TrialNetworks
May 7, 2025 at 11:58 AM
How can ECMC build international partnerships? Dr Natalie Cook (@oncocook) & Emma Kinloch (@London_Em1) join the international Consortia conversation on learning globally, acting locally. #ECMC2025 #TrialNetworks
Prof Christophe Massard & Dr Anna Patrikidou (@gustaveroussy.fr) showcase the CLIP network’s approach to early phase trials in France. What can we learn? Let’s find out. #ECMC2025 #GlobalCollaboration
May 7, 2025 at 11:33 AM
Prof Christophe Massard & Dr Anna Patrikidou (@gustaveroussy.fr) showcase the CLIP network’s approach to early phase trials in France. What can we learn? Let’s find out. #ECMC2025 #GlobalCollaboration
How can the UK regulatory landscape better support early phase trial delivery? Dr Kingyin Lee (@mhragovuk.bsky.social) & Kate Greenwood (@hralatest.bsky.social) explore challenges and opportunities—followed by an open Q&A. #ECMC2025
May 7, 2025 at 9:58 AM
How can the UK regulatory landscape better support early phase trial delivery? Dr Kingyin Lee (@mhragovuk.bsky.social) & Kate Greenwood (@hralatest.bsky.social) explore challenges and opportunities—followed by an open Q&A. #ECMC2025
Prof Patrick Chinnery addresses a pressing issue: the declining UK clinical research workforce. A vital conversation begins now with our ECMC Leads on how to reverse the decline #ECMC2025 #ResearchCareers
May 7, 2025 at 9:19 AM
Prof Patrick Chinnery addresses a pressing issue: the declining UK clinical research workforce. A vital conversation begins now with our ECMC Leads on how to reverse the decline #ECMC2025 #ResearchCareers
We're listening to a fascinating update on GLIMPS (IL13R CAR-T for high-grade glioma) and MIGHTY (Multi-modular CAR-T cells targeting B7-H3 in CYP sarcoma) by Dr Karin Straathof (UCL paediatric ECMC)
March 25, 2025 at 3:07 PM
We're listening to a fascinating update on GLIMPS (IL13R CAR-T for high-grade glioma) and MIGHTY (Multi-modular CAR-T cells targeting B7-H3 in CYP sarcoma) by Dr Karin Straathof (UCL paediatric ECMC)
We're continuing in the #CCLG2025's Clinical Trials (Solid & CNS Tumours session) with @newcastle-ecmc.bsky.social's Dr. Quentin Campbell-Hewson for an update on the New Agents Group!
March 25, 2025 at 2:03 PM
We're continuing in the #CCLG2025's Clinical Trials (Solid & CNS Tumours session) with @newcastle-ecmc.bsky.social's Dr. Quentin Campbell-Hewson for an update on the New Agents Group!
Dr John Apps (Birmingham ECMC) is presenting MonoGerm next– A Phase II trial of carboplatin or vinblastine monotherapy induction prior to radiotherapy for intracranial germinoma. Looking forward to an insightful afternoon with updates on exciting advancements s for paediatric solid & CNS tumours!
March 25, 2025 at 12:17 PM
Dr John Apps (Birmingham ECMC) is presenting MonoGerm next– A Phase II trial of carboplatin or vinblastine monotherapy induction prior to radiotherapy for intracranial germinoma. Looking forward to an insightful afternoon with updates on exciting advancements s for paediatric solid & CNS tumours!
What’s next for CYP oncology research? Professor Pam Kearns (Birmingham Paediatric ECMC) shares her thoughts at the Insights and Innovations sessions, discussing the future of CYP trials in the UK. #ECMC #CCLGResearch #PaediatricOncology #CCLG2025
March 24, 2025 at 3:55 PM
What’s next for CYP oncology research? Professor Pam Kearns (Birmingham Paediatric ECMC) shares her thoughts at the Insights and Innovations sessions, discussing the future of CYP trials in the UK. #ECMC #CCLGResearch #PaediatricOncology #CCLG2025
